Australia markets open in 6 hours 8 minutes

Artelo Biosciences, Inc. (ARTL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4400+0.0300 (+2.13%)
As of 12:41PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.50M
Enterprise value -2.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.47
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.21

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3-33.41%
S&P500 52-week change 323.99%
52-week high 32.9800
52-week low 31.1500
50-day moving average 31.4139
200-day moving average 31.4626

Share statistics

Avg vol (3-month) 313.86k
Avg vol (10-day) 314.42k
Shares outstanding 53.23M
Implied shares outstanding 63.23M
Float 83.2M
% held by insiders 10.83%
% held by institutions 10.77%
Shares short (15 May 2024) 46.2k
Short ratio (15 May 2024) 40.54
Short % of float (15 May 2024) 40.19%
Short % of shares outstanding (15 May 2024) 40.19%
Shares short (prior month 15 Apr 2024) 46.08k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 321 June 2019
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 310 Aug 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-44.34%
Return on equity (ttm)-70.68%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-9.6M
Diluted EPS (ttm)-3.1600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.61M
Total cash per share (mrq)2.36
Total debt (mrq)127k
Total debt/equity (mrq)1.33%
Current ratio (mrq)11.36
Book value per share (mrq)2.95

Cash flow statement

Operating cash flow (ttm)-8.96M
Levered free cash flow (ttm)-5.29M